Abstract

Introduction. Colorectal cancer (CRC) is an important cause of morbidity and mortality worldwide. Angiogenesis was reported as one important mechanism activated in colorectal carcinogenesis. Tumor microenvironment associated angiogenesis involves a large spectrum of signaling molecules and deciphering their role in colorectal carcinogenesis still represents a major challenge. The aim of our study is to point out the diagnosis and prediction role of PDGF family and their receptors in colorectal carcinogenesis. Material and Methods. A systematic search in Medline and PubMed for studies reporting the role of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in tumor biology related to CRC was made. Results. PDGFs are important growth factors for normal tissue growth and division, with an important role in blood vessel formation. PDGFs/PDGFRs signaling pathway has been demonstrated to be involved in angiogenesis mainly by targeting pericytes and vascular smooth muscle cells. High levels of PDGF-BB were reported in CRC patients compared to those with adenomas, while elevated levels of PDGFR α/β in the stroma of CRC patients were correlated with invasion and metastasis. Moreover, PDGF-AB and PDGF-C were correlated with early diagnosis, cancer grading, and metastatic disease. Conclusions. Both PDGFs and PDGFRs families play an important role in colorectal carcinogenesis and could be considered to be investigated as useful biomarkers both for diagnosis and treatment of CRC.

Highlights

  • Colorectal cancer (CRC) is an important cause of morbidity and mortality worldwide

  • The importance of VEGF, FGF, and TGFβ in tumor angiogenesis including in the colon carcinogenesis has been extensively analyzed in the literature [12,13,14]; in this review, we will focus on the role of platelet-derived growth factors (PDGFs)/PDGFRs in the CRC pathology

  • Our findings suggested that the level of PDGF-C peripheral blood might contribute to early diagnosis of CRC, and PDGF-C could be used as a noninvasive biomarker for CRC diagnosis

Read more

Summary

Introduction

Colorectal cancer (CRC) is an important cause of morbidity and mortality worldwide, especially due to the deficiency of early detection reliable biomarkers. The adenoma-carcinoma transition is recognized as playing a considerable role in colorectal tumorigenesis, and colorectal adenomas are seen as precursor lesions of CRC. Progression through this process is characterized by a complex interaction between environmental carcinogens, genetic mutations, and the host immune system, eventually leading to the uncontrolled growth of modified cells [1]. A single cytokine (e.g., growth factor) can activate signals of complex molecular cascades resulting in tumor progression and development. In line with this view, tumor angiogenesis and vasculature remodeling represent two important mechanisms activated in CRC. In this review we discuss the role of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in tumor biology related to CRC

The Role of PDGFs and PDGFRs in Colorectal Carcinogenesis
The Role of PDGFRs in Colorectal Carcinogenesis
The Role of PDGF-AB in Colorectal Carcinogenesis
The Role of PDGF-BB in Colorectal Carcinogenesis
The Role of PDGF-CC in Colorectal Carcinogenesis
The Role of PDGF-DD in Colorectal Carcinogenesis
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call